16Apr GlaxoSmithKline Pharmaceuticals informPursuant to Regulation 39 and other application regulations of SEBI (Lis..
05Apr GlaxoSmithKline Pharmaceuticals informPursuant to Regulation 39 and other application regulations of SEBI (Lis..
04Apr Glaxosmithkline Pharmaceuticals informPursuant to Regulation 39 and other application regulations of SEBI (Lis..
02Apr Glaxosmithkline Pharmaceuticals informIn Compliance with Regulation 74(5) of SEBI (Depositories and Participan..
02Apr GlaxoSmithKline Pharmaceuticals informAs required under Clause 7(3) of the Listing Obligations and Disclosure..